Many cancer patients treated with 5-fluorouracil experience life-threatening toxicity due to an inherited enzyme deficiency. We are establishing an assay to pre-screen for this deficiency using urine samples. In the future this could help Oncologists identify who is at risk and choose a better dose of 5-fluorouracil for their patients.
This poster was uploaded for the SGS Research Showcase 2023.